| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |